100 Binney Street

Owned by Alexandria Real Estate Equities, 100 Binney Street in Cambridge’s bustling Kendall Square neighborhood is a 10-story, Class A lab and office building that was completed in fall 2017. Code Red Consultants served as the smoke control special inspector responsible for commissioning the building’s two stair and four elevator pressurization life safety systems. To meet strict project schedule requirements, Code Red Consultants worked through the final night of testing in order for the building to receive its Certificate of Occupancy on the following day. The timely completion of the base building paved the way for interior fit-outs of tenant spaces to begin. Fully leased, the 431,500 SF building is now home to primary tenants Bristol-Myers Squibb and Facebook as well as four venture-backed biotech startups: Foghorn Therapeutics, Sigilon Therapeutics, Tango Therapeutics, and TCR2 Therapeutics.

Elkus Manfredi Associates was the architect and John Moriarty & Associates was the project’s general contractor. Northstar Project and Real Estate Services served as the owner’s project manager.

Location

Cambridge, Mass.

Size

431,500 SF

Cost

$485 million

Completion

2017

Photography Credit

Code Red Consultants

100 Binney Street

Owned by Alexandria Real Estate Equities, 100 Binney Street in Cambridge’s bustling Kendall Square neighborhood is a 10-story, Class A lab and office building that was completed in fall 2017. Code Red Consultants served as the smoke control special inspector responsible for commissioning the building’s two stair and four elevator pressurization life safety systems. To meet strict project schedule requirements, Code Red Consultants worked through the final night of testing in order for the building to receive its Certificate of Occupancy on the following day. The timely completion of the base building paved the way for interior fit-outs of tenant spaces to begin. Fully leased, the 431,500 SF building is now home to primary tenants Bristol-Myers Squibb and Facebook as well as four venture-backed biotech startups: Foghorn Therapeutics, Sigilon Therapeutics, Tango Therapeutics, and TCR2 Therapeutics.

Elkus Manfredi Associates was the architect and John Moriarty & Associates was the project’s general contractor. Northstar Project and Real Estate Services served as the owner’s project manager.